Polianta Ltd’s Ionis Pharmaceuticals IONS Stock Holding History

Polianta Ltd’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-16,800	Closed	-$1.08M	–	82
2019 Q2	$1.08M	Buy	+16,800	New	+$1.19M	0.47%	58

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polianta Ltd's IONS Position: Q3 2019 in Review

Polianta Ltd sold out of Ionis Pharmaceuticals (IONS) in Q3 2019, closing a stake of 16,800 shares — an estimated $1.08M sold.

Polianta Ltd first reported a position in IONS in Q2 2019 and held it in 1 quarter. The position peaked at $1.08M in Q2 2019. 369 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

Polianta Ltd reported no remaining Ionis Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Polianta Ltd sold 16,800 Ionis Pharmaceuticals shares in Q3 2019, an estimated $1.08M.
Polianta Ltd first reported a position in Ionis Pharmaceuticals in Q2 2019 and held it in 1 quarter.
Polianta Ltd's Ionis Pharmaceuticals position peaked at $1.08M in Q2 2019.
369 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on Polianta Ltd's 13F filing for Q3 2019, filed 9 Oct 2019.